𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rebif® Quality of Life (RebiQoL): A randomized, multicenter, Phase IIIb study evaluating quality-of-life measures in patients receiving the serum-free formulation of subcutaneous interferon beta-1a for the treatment of relapsing forms of multiple sclerosis

✍ Scribed by D. Bandari; D. Wynn; T. Miller; B. Singer; S. Wray; R. Bennett; B. Hayward; F. Dangond


Book ID
119330501
Publisher
Elsevier
Year
2013
Tongue
English
Weight
552 KB
Volume
2
Category
Article
ISSN
2211-0348

No coin nor oath required. For personal study only.